The NLRP3 inflammasome: a prospective therapeutic target for intracerebral haemorrhage
The NLRP3 inflammasome: a prospective therapeutic target for intracerebral haemorrhage
批准号:
2625623
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Following intracerebral haemorrhage (ICH), the toxic influx of blood into the brain initiates a pro-inflammatory response that drives the progression of brain injury and represents a potential therapeutic target. To-date, no specific drug treatments exist for ICH patients. As such, there is an urgent requirement to identify new candidate therapies.Inflammasomes, such as formed by NLRP3, are cytosolic multimeric protein complexes formed in inflammatory cells in response to pathogenic infection and tissue injury. Activated inflammasomes drive the processing of pro-inflammatory cytokine precursors such as pro-IL-1B and pro-IL-18 into mature secreted forms to initiate inflammation. Indeed, inflammasome activation plays a key role in driving brain injury following ICH and selective NLRP3 inhibition may be protective in rodent models.Through zebrafish drug screening, we have identified a series of small molecule compounds that can inhibit brain injury after ICH (PMID: 35098999). We hypothesise that some of these molecules offer protection through inhibiting the NLRP3 inflammasome. In this PhD, we will test this hypothesis by further screening these successful compounds in an in vitro model of inflammasome activation to test for efficacy. Candidates capable of inhibiting the NLRP3 inflammasome will be subsequently tested and interrogated in two separate in vivo ICH model systems (zebrafish and mouse) to determine effects on disease outcomes. As such, the student will gain training in cross-disciplinary translational research (medicinal chemistry, immunology, neuroscience), and acquire skills associated with cellular assays and zebrafish/mouse disease modelling.The student will join the wider Brain Inflammation group, a vibrant and successful group of non-clinical and clinical PI's, post-docs, students and technicians whose research spans from basic biology through to clinical practise. This diverse research environment provides a stimulating and fun place to work and train.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
视网膜色素上皮细胞中YAP/mtDNA/cGAS-炎症小体轴在干性年龄相关性黄斑变性中的作用
-
批准号:82371073
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄珮戎
-
依托单位:
自噬流/炎症小体失衡在新生儿缺血缺氧性脑病中的作用机制
-
批准号:82372205
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:崔德荣
-
依托单位:
LTB4/BLT1轴调控NLRP3炎症小体对糖尿病认知功能障碍的作用研究
-
批准号:82371213
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:王修哲
-
依托单位:
mt DNA/AIM2 inflammasome/ neuronal pyroptosis途径参与创伤性颅脑损伤后认知功能障碍发生的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:盛江涛
-
依托单位:
TRPV1通过CaMKII-AMPK/NLRP3通路调控巨噬细胞破骨化在腹主动脉瘤中的作用机制研究
-
批准号:82100502
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李雪灵
-
依托单位:
急性肺损伤中AQP3在NLRP3炎症小体介导的肺巨噬细胞焦亡中的作用
-
批准号:32060158
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:阿不都许库尔·阿不力米提
-
依托单位:
NLRP3-inflammasome介导的细胞焦亡在脑出血神经元继发性损伤的作用和机制研究
-
批准号:81901220
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:初翔
-
依托单位:
AngII—NLRP3 Inflammasome 信号通路在湿热应激心脏损伤中的作用机制研究
-
批准号:81671885
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2016
-
负责人:王晓武
-
依托单位:
小胶质细胞焦亡及其NLRP/inflammasome/caspase-1调控通路在脑出血中的作用机制
-
批准号:81571108
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:张相彤
-
依托单位:
腺泡细胞焦亡及其HIF/Inflammasome/Caspase-1调控通路在急性胰腺炎中的作用及机制研究
-
批准号:81470887
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:白雪巍
-
依托单位: